+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Enteric Disease Testing Market by Test Method (Biochemical Tests, Culture Methods, Immunoassays), Product Type (Consumables, Instruments, Software & Services), End User, Pathogen, Sample Type, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674144
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The enteric disease testing market is rapidly transforming as healthcare systems worldwide adopt innovative diagnostic tools to address the growing burden of gastrointestinal pathogens. Senior leaders require actionable market intelligence to guide strategic investments and navigate evolving clinical and regulatory environments, making access to reliable, up-to-date analysis essential for sustainable decision-making.

Market Snapshot: Enteric Disease Testing Market Size & Growth Outlook

The global enteric disease testing market grew from USD 4.54 billion in 2024 to USD 4.80 billion in 2025 and is projected to continue its upward trajectory with a compound annual growth rate (CAGR) of 5.50%, reaching USD 6.26 billion by 2030. This sustained expansion is driven by rising public health concerns, increasing incidence of gastrointestinal infections, growing awareness of antimicrobial resistance, and the critical need for rapid, accurate pathogen detection across healthcare settings.

Scope & Segmentation

This report comprehensively analyzes the enteric disease testing industry across the value chain, focusing on key segments, product innovations, and regional market dynamics.

  • Test Methods: Includes biochemical tests (both automated and manual analysis), culture methods (non-selective and selective), immunoassays (chemiluminescence, enzyme-linked immunosorbent, lateral flow), molecular diagnostics (loop-mediated isothermal amplification, polymerase chain reaction, real-time PCR), and sequencing (next-generation and Sanger approaches).
  • Product Types: Covers consumables such as kits and reagents, instruments including immuno analyzers, PCR instruments, sequencers, and software & services like data analysis and maintenance support.
  • End Users: Addresses academic and clinical laboratories, diagnostic labs, hospitals, and research institutes as primary stakeholders.
  • Pathogens: Segmentation focuses on detection of bacterial agents (e.g., Campylobacter, Escherichia coli, Salmonella), viral agents (adenovirus, norovirus, rotavirus), and parasitic pathogens.
  • Sample Types: Analyses are conducted on blood samples, rectal swabs, and stool specimens, each requiring specific preparatory protocols.
  • Distribution Channels: Assesses direct sales, distributor networks, and online channels, reflecting the trend toward diversified procurement strategies.
  • Regional Coverage: Examines market dynamics across Americas (including United States, Canada, Latin America), Europe, Middle East & Africa, and Asia-Pacific regions, providing situational insights into regulatory environments and adoption rates.

Key Takeaways for Senior Decision-Makers

  • The diagnostic landscape is shifting toward multiplex platforms and rapid, high-throughput workflows, empowering clinical laboratories to identify and differentiate emerging gastrointestinal pathogens efficiently.
  • Healthcare providers increasingly demand decentralized and point-of-care testing formats, reflecting a need for actionable results in emergency, outpatient, and resource-limited contexts.
  • Advanced automation, intelligent software, and data-driven tools are reducing manual intervention and enhancing laboratory productivity, allowing skilled personnel to focus on value-added decision-making.
  • Regionalization of manufacturing and a diversified supplier base are now strategic priorities to strengthen supply chain resilience and minimize exposure to regulatory shocks.
  • Collaborative innovation between industry leaders, academic researchers, and public health agencies accelerates deployment of context-specific products and training, essential for market access and trust-building.

Tariff Impact and Supply Chain Strategies

Recent United States tariffs on imported diagnostic reagents and instruments in 2025 have pushed manufacturers and laboratories to re-evaluate sourcing, cost management, and procurement strategies. This has led to increased focus on domestic material sourcing, exploration of tariff-exempt production zones, and enhanced supplier diversification. Healthcare organizations are adopting multi-year service contracts, bulk agreements, and value-based pricing models to offset rising input costs while ensuring continuity of access to advanced enteric disease testing solutions.

Methodology & Data Sources

The analysis synthesizes robust secondary research from peer-reviewed literature, regulatory reports, technical white papers, and corporate disclosures. Primary data was gathered through interviews with laboratory directors, infectious disease specialists, supply chain managers, and end users to validate findings and provide a grounded perspective on prevailing market sentiment and operational pain points.

Why This Report Matters

  • Enables executive leaders to assess changing market dynamics, technology adoption, and emerging risks for informed decision-making.
  • Supports procurement and product strategy by highlighting opportunities in advanced diagnostics, regional supply chains, and targeted investment in resilient infrastructure.
  • Offers a practical framework for optimizing organizational diagnostic portfolios, enhancing regulatory compliance, and aligning with patient care priorities on a global scale.

Conclusion

Senior stakeholders equipped with comprehensive, data-driven insights from this report will be well positioned to optimize their diagnostic strategies, respond to evolving regulatory and tariff environments, and drive sustained growth in the enteric disease testing market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of multiplexed molecular panels for simultaneous detection of multiple enteric pathogens reducing diagnosis time
5.2. Adoption of rapid point of care immunoassays for community based detection of norovirus and rotavirus infections
5.3. Integration of next generation sequencing in clinical settings for comprehensive outbreak source tracking and antimicrobial resistance profiling
5.4. Deployment of CRISPR based diagnostic platforms for ultra sensitive detection of low abundance enteric pathogens in stool samples
5.5. Strategic partnerships between diagnostic manufacturers and telehealth providers to facilitate remote enteric disease testing and consultation
5.6. Implementation of digital stool diagnostics coupled with AI analytics for predictive modeling of enteric disease outbreaks in public health surveillance
5.7. Regulatory approval and commercialization of lab on a chip devices for portable multiplexed detection of bacterial viral and parasitic enteric agents
5.8. Rising demand for fecal microbiome testing as a complementary tool for differential diagnosis and personalized treatment of gastrointestinal infections
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Enteric Disease Testing Market, by Test Method
8.1. Introduction
8.2. Biochemical Tests
8.2.1. Automated Biochemical Analysis
8.2.2. Manual Biochemical Tests
8.3. Culture Methods
8.3.1. Non Selective Culture
8.3.2. Selective Culture
8.4. Immunoassays
8.4.1. Chemiluminescence Immunoassay
8.4.2. Enzyme Linked Immunosorbent Assay
8.4.3. Lateral Flow Assay
8.5. Molecular Diagnostics
8.5.1. Loop Mediated Isothermal Amplification
8.5.2. Polymerase Chain Reaction
8.5.3. Real Time Polymerase Chain Reaction
8.6. Sequencing
8.6.1. Next Generation Sequencing
8.6.2. Sanger Sequencing
9. Enteric Disease Testing Market, by Product Type
9.1. Introduction
9.2. Consumables
9.2.1. Kits
9.2.2. Reagents
9.3. Instruments
9.3.1. Immuno Analyzers
9.3.2. Polymerase Chain Reaction Instruments
9.3.3. Sequencers
9.4. Software & Services
9.4.1. Data Analysis Software
9.4.2. Maintenance Services
10. Enteric Disease Testing Market, by End User
10.1. Introduction
10.2. Academic And Clinical Laboratories
10.3. Diagnostic Laboratories
10.4. Hospitals
10.5. Research Institutes
11. Enteric Disease Testing Market, by Pathogen
11.1. Introduction
11.2. Bacterial Pathogens
11.2.1. Campylobacter
11.2.2. Escherichia Coli
11.2.3. Salmonella
11.3. Parasitic Pathogens
11.4. Viral Pathogens
11.4.1. Adenovirus
11.4.2. Norovirus
11.4.3. Rotavirus
12. Enteric Disease Testing Market, by Sample Type
12.1. Introduction
12.2. Blood Samples
12.3. Rectal Swabs
12.4. Stool Samples
13. Enteric Disease Testing Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Distributors
13.4. Online Sales
14. Americas Enteric Disease Testing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Enteric Disease Testing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Enteric Disease Testing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. bioMérieux SA
17.3.3. Abbott Laboratories
17.3.4. Roche Holding AG
17.3.5. QIAGEN N.V.
17.3.6. Becton, Dickinson and Company
17.3.7. Bio-Rad Laboratories, Inc.
17.3.8. Danaher Corporation
17.3.9. PerkinElmer, Inc.
17.3.10. DiaSorin S.p.A.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ENTERIC DISEASE TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ENTERIC DISEASE TESTING MARKET: RESEARCHAI
FIGURE 28. ENTERIC DISEASE TESTING MARKET: RESEARCHSTATISTICS
FIGURE 29. ENTERIC DISEASE TESTING MARKET: RESEARCHCONTACTS
FIGURE 30. ENTERIC DISEASE TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ENTERIC DISEASE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY AUTOMATED BIOCHEMICAL ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY AUTOMATED BIOCHEMICAL ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MANUAL BIOCHEMICAL TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MANUAL BIOCHEMICAL TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY NON SELECTIVE CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY NON SELECTIVE CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SELECTIVE CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SELECTIVE CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNO ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNO ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ACADEMIC AND CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ACADEMIC AND CLINICAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CAMPYLOBACTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CAMPYLOBACTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SALMONELLA, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SALMONELLA, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PARASITIC PATHOGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PARASITIC PATHOGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ADENOVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ADENOVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY NOROVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY NOROVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ROTAVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ROTAVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RECTAL SWABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RECTAL SWABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY STOOL SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY STOOL SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 201. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 202. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 203. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2024 (USD MILLION)
TABLE 204. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2025-2030 (USD MILLION)
TABLE 205. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 206. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 207. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 208. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 209. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 210. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 211. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 212. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 213. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 216. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 217. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 218. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 219. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 220. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 221. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 224. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 225. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2024 (USD MILLION)
TABLE 226. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, 2025-2030 (USD MILLION)
TABLE 227. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, 2018-2024 (USD MILLION)
TABLE 228. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, 2025-2030 (USD MILLION)
TABLE 229. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 230. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 231. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 234. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 235. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 238. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 239. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 240. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 241. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 242. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 243. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 244. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 245. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 248. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 249. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 250. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 251. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 252. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 253. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 256. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 257. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2024 (USD MILLION)
TABLE 258. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, 2025-2030 (USD MILLION)
TABLE 259. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, 2018-2024 (USD MILLION)
TABLE 260. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, 2025-2030 (USD MILLION)
TABLE 261. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 262. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 263. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL PATHOGENS, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL PATHOGENS, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY BIOCHEMICAL TESTS, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 32

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Enteric Disease Testing market report include:
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Abbott Laboratories
  • Roche Holding AG
  • QIAGEN N.V.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc.
  • DiaSorin S.p.A.

Table Information